Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Study Objectives: To investigate sleep perception during a 32-hour continuous bedrest polysomnography in patients with idiopathic hypersomnia (IH), non-specified hypersomnia (NSH) and healthy controls (HC).

Methods: Patients with suspected IH, and HC (n=14) underwent a regular polysomnography, a modified multiple sleep latency test (MSLT) and a 32-hour bedrest protocol, from 11PM till 7AM the day after, without circadian synchronizers. Patients were diagnosed with IH with long-sleep-time (IH-LST, n=72) if they had a positive bedrest (sleep duration≥19h), without LST (IH-nLST, n=10, sleep duration<19h, MSLT mean sleep latency≤8min), or NSH otherwise (n=26). Afterward participants estimated their sleep periods over the 32 hours. Relative errors were computed from perceived and objective sleep durations, compared across groups and analyzed in relation to clinical and sleep parameters.

Results: NSH and IH-nLST showed higher relative errors compared to IH-LST and HC, during the whole bedrest (median error respectively 33.9%, 22.8%, 2.4%, 5.9%, p<0.01), and specifically during daytime (7AM-11PM, p<0.01) and the second night (11PM-7AM, p<0.01). A linear negative association of relative error was found with objective sleep duration, shorter sleepers overestimating more their sleep duration, with a steeper covariance in NSH and IH-nLST (p<0.01). Adjusted on objective sleep duration, sleep overestimation was associated with subjective and objective daytime sleepiness, and increased number of sleep bouts.

Conclusions: Overestimation of sleep duration is frequent in patients with hypersomnolence during a free-running PSG, especially in IH-nLST and particularly severe in NSH. This is a first step towards understanding the mismatch between subjective complaints and objective measures in these patients.

Download full-text PDF

Source
http://dx.doi.org/10.1093/sleep/zsaf131DOI Listing

Publication Analysis

Top Keywords

idiopathic hypersomnia
8
sleep
5
sleep overestimation
4
overestimation differentiates
4
differentiates participants
4
participants suspected
4
suspected idiopathic
4
hypersomnia study
4
study objectives
4
objectives investigate
4

Similar Publications

Objective: This study aimed to identify distinct REM sleep characteristics that differentiate type 1 narcolepsy (NT1) from type 2 narcolepsy (NT2) using polysomnography (PSG), while acknowledging the need for future validation against other hypersomnia disorders.

Methods: A retrospective review included 31 patients with NT1, 21 patients with NT2, and 24 healthy participants. Each participant underwent overnight PSG and a subsequent multiple sleep latency test (MSLT) to assess REM sleep parameters including average REM density, neck myoclonus index, and leg movement index.

View Article and Find Full Text PDF

Idiopathic hypersomnia (IH) is a rare and chronic neurological sleep disorder in which patients experience excessive daytime sleepiness (EDS) with symptoms often overlapping with numerous other sleep conditions. This diagnostic overlap can further delay accurate diagnosis and treatment, which poses significant challenges for both patients and clinicians. Additionally, vulnerable populations, such as those with Down syndrome (DS), face further obstacles given the absence of therapeutic studies addressing IH in DS.

View Article and Find Full Text PDF

Idiopathic hypersomnia (IH) is a chronic, neurologic disorder with a primary symptom of excessive daytime sleepiness. There are challenges to timely, accurate diagnosis of IH and, therefore, to optimal management. To better understand these challenges and identify opportunities, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2024.

View Article and Find Full Text PDF

Narcolepsy 2025 (with an Australasian perspective).

Intern Med J

August 2025

CIRUS Centre for Sleep and Chronobiology, Woolcock Institute of Medical Research, Macquarie University, Sydney, New South Wales, Australia.

Narcolepsy is a disorder of central hypersomnolence, which, while uncommon, can carry profound implications for affected individuals. Despite this, it remains under-recognised within the medical community and presents frequent diagnostic and treatment challenges in the Australasian setting. Narcolepsy is subdivided into narcolepsy type 1, characterised by cataplexy and deficiency of the neuropeptide orexin, and narcolepsy type 2, a distinct entity.

View Article and Find Full Text PDF

Hypersomnia may be classified as primary or secondary, with secondary hypersomnia arising from a variety of underlying causes. Thus, according to ICSD3-TR classification, the diagnosis of idiopathic hypersomnia (IH) is established based on (1) excessive daytime sleepiness (EDS); (2) electrophysiological findings including either a mean sleep latency of less than 8 min on the Multiple Sleep Latency Test (MSLT) or increased total sleep (≥11 h) on 24 h polysomnography; and (3) systematic elimination of other potential etiologies, including sleep deprivation, substances, and medical, psychiatric (notably mood disorders), or sleep disorders. Nevertheless, the clinical heterogeneity observed in IH fuels an ongoing debate, reflecting the limited understanding of its underlying pathophysiological mechanisms.

View Article and Find Full Text PDF